D5DR Inhibitors
Items 1 to 10 of 15 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SCH 39166 hydrobromide | 1227675-51-5 | sc-204270 sc-204270A | 10 mg 50 mg | $229.00 $923.00 | ||
SCH 39166 hydrobromide is a selective D5 dopamine receptor antagonist, characterized by its unique ability to stabilize receptor conformations, thereby modulating downstream signaling pathways. Its distinct molecular interactions involve hydrogen bonding and hydrophobic contacts, which influence receptor affinity and selectivity. The compound exhibits notable kinetic properties, allowing for rapid receptor engagement and dissociation, which can affect the duration of its action in various biological contexts. | ||||||
Haloperidol hydrochloride | 1511-16-6 | sc-203593 | 100 mg | $71.00 | 1 | |
Haloperidol hydrochloride acts as a potent D5 dopamine receptor antagonist, exhibiting unique conformational dynamics that influence receptor activation states. Its molecular interactions are characterized by a combination of ionic and hydrophobic forces, enhancing binding specificity. The compound's kinetic profile reveals a rapid association and dissociation rate, facilitating transient receptor modulation. Additionally, its solubility properties in aqueous environments contribute to its behavior in various chemical contexts. | ||||||
SCH 23390 | 125941-87-9 | sc-200408 sc-200408A | 5 mg 25 mg | $175.00 $719.00 | 2 | |
A selective antagonist for D1 and D5 dopamine receptors, directly binding to these receptors to inhibit their activity. | ||||||
Chlorprothixene Hydrochloride | 6469-93-8 | sc-211077 | 1 g | $61.00 | 2 | |
Chlorprothixene Hydrochloride functions as a selective D5 dopamine receptor modulator, showcasing distinctive binding affinities that alter receptor conformations. Its molecular interactions are marked by a balance of polar and non-polar interactions, which fine-tune its affinity for the receptor. The compound exhibits unique reaction kinetics, with a notable lag phase in binding, suggesting complex conformational changes. Its stability in diverse pH environments further influences its reactivity and interaction profiles. | ||||||
(−)-Butaclamol hydrochloride | 55528-08-0 | sc-252526 | 25 mg | $115.00 | ||
An antipsychotic known to antagonize various dopamine receptors, including D5DR, by direct interaction. | ||||||
Fluphenazine Hydrochloride | 146-56-5 | sc-205700 sc-205700A sc-205700B sc-205700C | 1 g 5 g 50 g 100 g | $205.00 $454.00 $1025.00 $1538.00 | ||
A phenothiazine antipsychotic, acting as a dopamine receptor antagonist and potentially influencing D5DR activity. | ||||||
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
A widely used antipsychotic that antagonizes dopamine receptors, likely including D5DR, by directly binding to the receptor sites. | ||||||
Domperidone | 57808-66-9 | sc-203032 sc-203032A | 50 mg 250 mg | $60.00 $281.00 | 2 | |
Primarily a D2 receptor antagonist, but its effects on dopamine receptors may extend to D5DR. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $60.00 $108.00 | 21 | |
An antipsychotic that blocks various dopamine receptors, potentially including D5DR. | ||||||
L-741,626 | 81226-60-0 | sc-252936 | 10 mg | $114.00 | 1 | |
A selective D2 receptor antagonist, which may have indirect effects on D5DR signaling. | ||||||